We are live on
!
Find out more
Vident Advisory Portfolio holdings
AUM
$13.9B
Turnover
17.94%
1-Year Est. Return
53.47%
This Fund
S&P 500
This Quarter
Est. Return
+33.82%
1 Year Est. Return
+53.47%
3 Year Est. Return
+164.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13.9B
AUM Growth
+$2.11B
(+18%)
Cap. Flow
-$471M
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
20.48%
Holding
2,062
New
227
Increased
871
Reduced
739
Closed
143
Avg Time Held Equity + Options
1.6
years
Top 10 Avg Time Held Equity + Options
1.3
years
Top 20 Avg Time Held Equity + Options
1.5
years
Avg Time Held Equity only
1.6
years
Top 10 Avg Time Held Equity only
1.3
years
Top 20 Avg Time Held Equity only
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$31.6M |
| 2 |
Spotify
SPOT
|
+$27.5M |
| 3 |
Palantir
PLTR
|
+$26.2M |
| 4 |
Watsco Inc
WSO
|
+$19.5M |
| 5 |
Capital One
COF
|
+$19.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$243M |
| 2 |
Tesla
TSLA
|
+$101M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$89.9M |
| 4 |
Palo Alto Networks
PANW
|
+$82.2M |
| 5 |
Advanced Micro Devices
AMD
|
+$67.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.61% |
| 2 | Industrials | 13.56% |
| 3 | Financials | 10.73% |
| 4 | Miscellaneous | 8.13% |
| 5 | Consumer Discretionary | 6.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
The Frontier Economic Fund
AKAF
$2.86M
| $2.39M | 0.02% |
75,782
| – | – |
2025 Q3
3 quarters
|
|
627
Compañía de Minas Buenaventura
BVN
$7.72B
| $2.38M | 0.02% |
81,310
-10,046
| -11% | -$341K |
2023 Q3
11 quarters
|
|
628
Boston Properties
BXP
$9.46B
| $2.37M | 0.02% |
35,786
+825
| +2% | +$49.4K |
2023 Q3
11 quarters
|
|
629
Nike
NKE
$55.1B
| $2.37M | 0.02% |
57,769
-4,555
| -7% | -$200K |
2023 Q3
11 quarters
|
|
630
Carvana
CVNA
$64.3B
| $2.35M | 0.02% |
35,766
-4,614
| -11% | -$326K |
2025 Q1
5 quarters
|
|
631
Royal Bank of Canada
RY
$274B
| $2.35M | 0.02% |
11,344
+249
| +2% | +$46.2K |
2024 Q1
9 quarters
|
|
632
Agilent Technologies
A
$48.7B
| $2.35M | 0.02% |
17,675
-584
| -3% | -$71.2K |
2023 Q3
11 quarters
|
|
633
Medpace
MEDP
$17.1B
| $2.35M | 0.02% |
4,428
+154
| +4% | +$71.1K |
2023 Q3
11 quarters
|
|
634
Kontoor Brands
KTB
$3.99B
| $2.34M | 0.02% |
+28,045
| New | +$2.05M |
2026 Q2
0 quarters
|
|
635
iShares MSCI ACWI ex US ETF
ACWX
$17.4B
| $2.34M | 0.02% |
30,682
+21,993
| +253% | +$1.64M |
2023 Q3
11 quarters
|
|
636
Aegon
AEG
$12.3B
| $2.33M | 0.02% |
276,535
-28,023
| -9% | -$231K |
2023 Q3
11 quarters
|
|
637
Coeur Mining
CDE
$15.8B
| $2.33M | 0.02% |
142,878
-3,480
| -2% | -$63.4K |
2025 Q4
2 quarters
|
|
638
Vanguard Morningstar Large-Cap ETF
VV
$54.1B
| $2.33M | 0.02% |
+6,765
| New | +$2.26M |
2026 Q2
0 quarters
|
|
639
Hudbay
HBM
$10.5B
| $2.31M | 0.02% |
97,941
-5,644
| -5% | -$143K |
2023 Q3
11 quarters
|
|
640
Montana Technologies Corp
AIRJ
$226M
| $2.31M | 0.02% |
417,058
+96,057
| +30% | +$372K |
2025 Q4
2 quarters
|
|
641
Takeda Pharmaceutical
TAK
$62.9B
| $2.31M | 0.02% |
143,921
+68,885
| +92% | +$1.14M |
2024 Q2
8 quarters
|
|
642
Carlisle Companies
CSL
$13.2B
| $2.29M | 0.02% |
6,305
+3,427
| +119% | +$1.2M |
2023 Q4
10 quarters
|
|
643
Napco Security Technologies
NSSC
$1.26B
| $2.28M | 0.02% |
60,130
+11,239
| +23% | +$446K |
2026 Q1
1 quarter
|
|
644
Valvoline
VVV
$4B
| $2.28M | 0.02% |
+57,685
| New | +$2.01M |
2026 Q2
0 quarters
|
|
645
AppFolio
APPF
$7.49B
| $2.28M | 0.02% |
14,221
+3,098
| +28% | +$495K |
2024 Q1
9 quarters
|
|
646
Citizens Financial Group
CFG
$26.5B
| $2.27M | 0.02% |
32,406
-2,423
| -7% | -$156K |
2023 Q3
11 quarters
|
|
647
Credo Technology Group
CRDO
$31.9B
| $2.27M | 0.02% |
8,348
+4,597
| +123% | +$908K |
2025 Q2
4 quarters
|
|
648
Vanguard Morningstar Value ETF
VTV
$190B
| $2.26M | 0.02% |
10,388
+8,456
| +438% | +$1.77M |
2023 Q3
11 quarters
|
|
649
Baker Hughes
BKR
$55.2B
| $2.26M | 0.02% |
40,748
+2,352
| +6% | +$149K |
2023 Q3
11 quarters
|
|
650
Neurocrine Biosciences
NBIX
$13.8B
| $2.25M | 0.02% |
13,348
+11,351
| +568% | +$1.68M |
2025 Q1
5 quarters
|
|
Similar funds
Vident Advisory's Q2 2026 Portfolio in Review
As of Q2 2026, Vident Advisory held 2,062 positions worth $13.9B, up 18% from $11.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Vident Advisory withdrew a net $471M in Q2 2026, closing 143 positions and reducing 739 holdings. Its most notable exit was iShares MSCI Emerging Markets ex China ETF, an estimated $58.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Industrials and Financials.
Against the trend, Vident Advisory opened a new position in Honeywell Aerospace worth $8.59M.
- Vident Advisory's largest Q2 2026 buy was Honeywell Aerospace: 38,838 shares worth $8.59M.
- Vident Advisory added most to Sandisk in Q2 2026, an estimated $31.6M increase.
- Vident Advisory's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $243M.
- Vident Advisory fully exited iShares MSCI Emerging Markets ex China ETF in Q2 2026, selling an estimated $58.8M.
- Vident Advisory's ten largest holdings make up 20% of its $13.9B portfolio in Q2 2026.
- Vident Advisory opened 227 new positions and closed 143 in Q2 2026.
- Vident Advisory's portfolio value rose 18% quarter-over-quarter to $13.9B.
Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.